5.3 Neonatal Resuscitation & High-Risk Newborn Nursing

5.3 Neonatal Resuscitation & High-Risk Newborn Nursing

The APGAR Scoring System

Immediately following delivery, the most critical nursing priority is facilitating the neonate's transition from intrauterine to extrauterine life. The APGAR score is a rapid, standardized assessment tool used to evaluate the newborn's physiological status and response to resuscitation. It is routinely performed at 1 minute and 5 minutes after birth. If the 5-minute score is less than 7, additional scoring should be completed every 5 minutes up to 20 minutes.

The APGAR acronym evaluates five specific parameters, each scored from 0 to 2:

A total score of 7-10 indicates a robust newborn adjusting well. A score of 4-6 indicates moderate distress, often requiring supplemental oxygen and stimulation. A score of 0-3 indicates severe distress, mandating immediate, aggressive resuscitation.

Neonatal Resuscitation Program (NRP)

While most newborns transition smoothly, roughly 10% require some assistance to begin breathing, and 1% require extensive resuscitation. The Neonatal Resuscitation Program (NRP) algorithm dictates a specific sequence of interventions based on the neonate's vital signs, specifically heart rate and respiratory effort.

The initial steps for every newborn are: Warm, Dry, and Stimulate. The baby is placed on a radiant warmer, dried vigorously with warm towels (which also serves as tactile stimulation to breathe), and the wet linens are removed to prevent evaporative heat loss. The airway is cleared with a bulb syringe (mouth first, then nose) if secretions are obstructing breathing.

If the newborn remains apneic, is gasping, or has a heart rate below 100 bpm, the immediate intervention is to initiate Positive Pressure Ventilation (PPV) using a T-piece resuscitator or bag-mask device with room air (21% oxygen for term infants). The chest should be observed for gentle rise and fall.

If, after 30 seconds of effective PPV, the heart rate drops below 60 bpm, the nurse must initiate chest compressions coordinated with PPV at a ratio of 3 compressions to 1 breath. The oxygen concentration should be increased to 100%.

If the heart rate remains persistently below 60 bpm despite 60 seconds of effective chest compressions and PPV, the administration of emergency medications, specifically intravenous Epinephrine, is indicated. Access is typically secured via the umbilical vein.

Thermoregulation & Cold Stress

Neonates are extremely vulnerable to heat loss due to their large body surface area-to-mass ratio, thin skin, and lack of subcutaneous fat. They lose heat through four mechanisms:

• Evaporation: Heat loss as liquid on the skin turns to vapor (e.g., amniotic fluid drying post-delivery).
• Conduction: Direct heat loss to cooler objects in contact with the skin (e.g., placing the infant on a cold scale).
• Convection: Heat loss to cooler ambient air currents (e.g., drafts from air conditioning).
• Radiation: Heat loss to cooler solid objects nearby, even if not in direct contact (e.g., placing the crib near a cold window).

Unlike adults, neonates cannot shiver to generate heat. Instead, they rely on non-shivering thermogenesis, a metabolic process that burns highly vascular brown fat reserves. If heat loss exceeds the infant's ability to produce heat, Cold Stress ensues. Cold stress causes a cascade of detrimental physiological events: it dramatically increases oxygen consumption (leading to hypoxia), rapidly depletes glucose stores (leading to severe hypoglycemia), and increases pulmonary vasoconstriction, which can lead to respiratory distress and a return to fetal circulation pathways.

Respiratory Distress Syndrome (RDS)

Respiratory Distress Syndrome (RDS) primarily affects premature infants due to a critical lack of pulmonary surfactant. Surfactant is a lipoprotein that coats the alveoli, lowering surface tension and preventing alveolar collapse (atelectasis) during exhalation. Without sufficient surfactant, the infant must expend immense effort to reinflate the lungs with every breath, leading to rapid exhaustion and respiratory failure.

Clinical manifestations of RDS include tachypnea (respiratory rate > 60 breaths/min), intercostal and subcostal retractions, nasal flaring, an expiratory grunt (an attempt to maintain positive airway pressure), and central cyanosis. Nursing management requires a highly controlled NICU environment. Interventions include the administration of exogenous surfactant directly into the lungs via an endotracheal tube, respiratory support utilizing Continuous Positive Airway Pressure (CPAP) or mechanical ventilation, and meticulous monitoring of arterial blood gases and pulse oximetry.

Neonatal Hyperbilirubinemia

Hyperbilirubinemia is the accumulation of unconjugated bilirubin in the blood, presenting clinically as jaundice (yellowing of the skin and sclera). It is critical to differentiate between the two types:

• Physiological Jaundice: Benign and extremely common. It appears after the first 24 hours of life. It results from the normal breakdown of fetal red blood cells and the relative immaturity of the neonatal liver to conjugate and excrete the bilirubin.
• Pathological Jaundice: Appears within the first 24 hours of life and is indicative of an underlying pathological process, most commonly ABO or Rh blood group incompatibility between the mother and infant, leading to rapid hemolysis.

If unconjugated bilirubin levels cross the blood-brain barrier, it can cause kernicterus, a permanent, devastating neurological injury. The primary treatment for elevated bilirubin is phototherapy, which uses specific blue-spectrum light to convert unconjugated bilirubin into water-soluble isomers that can be easily excreted in urine and stool.

Nursing care during phototherapy is intensive. The infant must wear opaque eye patches to prevent retinal damage and a diaper to shield the gonads. To maximize skin exposure, the infant is otherwise naked. The nurse must frequently reposition the infant (every 2 hours), continuously monitor the infant's temperature to prevent hyperthermia under the lights, and strictly monitor intake and output (I&Os) and daily weights, as phototherapy significantly increases insensible fluid loss and the risk of dehydration.

Neonatal Hypoglycemia & Neonatal Abstinence Syndrome (NAS)

Neonatal Hypoglycemia is generally defined as a blood glucose level below 40-45 mg/dL. Infants at high risk include those born to diabetic mothers (who have hyperinsulinemia from fetal exposure to high maternal glucose), Large for Gestational Age (LGA) infants, Small for Gestational Age (SGA) infants, and premature infants who lack adequate glycogen stores. Signs of hypoglycemia are often subtle and include jitteriness, tremors, lethargy, poor feeding, apnea, a weak or high-pitched cry, and in severe cases, seizures. Immediate management involves early and frequent enteral feedings (breastmilk or formula). If the infant is symptomatic or if glucose levels remain critically low despite feeding, an intravenous infusion of dextrose (e.g., D10W) is required.

Neonatal Abstinence Syndrome (NAS) refers to a constellation of withdrawal symptoms observed in infants exposed to addictive substances in utero, most commonly opioids. Symptoms typically emerge within 24-72 hours after birth and affect multiple organ systems. Neurological signs include severe irritability, a continuous high-pitched cry, marked tremors, hyperactive reflexes, and disturbed sleep patterns. Gastrointestinal signs include frantic but uncoordinated sucking, poor feeding, vomiting, and explosive diarrhea.

Nurses use standardized assessment tools, such as the Finnegan Scoring System, to objectively quantify the severity of withdrawal and guide treatment. Non-pharmacological nursing interventions are the first line of defense: providing a dark, quiet, low-stimulation environment, swaddling the infant tightly with hands near the face, and offering small, frequent, high-calorie feedings. If non-pharmacological measures fail to control symptoms and the Finnegan scores remain high, pharmacological intervention with weight-based weaning doses of methadone or morphine is instituted.